Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ORIEN Member Presentations at 2023 ASCO Demonstrate Unique Value of Aster Insights' Data | ||
By: PR Newswire Association LLC. - 30 May 2023 | Back to overview list |
|
Research Focuses on Cancer Immunotherapy, Tumor Biology, and Inherited Risks TAMPA, Fla., May 30, 2023 /PRNewswire/ -- Aster Insights ("the Company"), the leading provider of technology-enabled data and analytics solutions for oncology discovery, today announced its participation as a research partner at the American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, 2023 in Chicago, IL. An oral presentation and three posters will be presented at this year's ASCO meeting, utilizing the lifetime patient-consented longitudinal clinicogenomic data from the Company's Oncology Research Information Exchange Network® (ORIEN) AVATAR program. These presentations highlight the research partnerships and collaboration of Aster Insights and 18 premier cancer centers that comprise ORIEN. "We are thrilled to be selected for these diverse presentations at ASCO that showcase the incredible work of ORIEN and Aster Insights," said Jill Kolesar, PharmD, Director of the Precision Medicine Center at the Markey Cancer Center and Chair of the ORIEN Executive Advisory Committee. "The partnership in research and broad national collaboration that define our work help drive critical breakthroughs in discovery and the development of next generation treatments for cancer patients." The research projects focus on cancer immunotherapy, risk reduction, and reporting inherited cancer risks. Partnering with the ORIEN members, Aster Insights enables critical scientific intelligence and insights to advance patient care by providing the richest real-world dataset in oncology, comprised of whole exome sequencing (WES), whole transcriptome sequencing (WTS), germline data, and lifetime clinical patient data. The full schedule of ORIEN presentations for June 3rd:
Aster Insights looks forward to meeting with ASCO attendees, oncology colleagues and research partners, at our booth (#23174) throughout the conference. For more information about our ASCO presentations, please contact Aster Insights at: media@asterinsights.com About Aster Insights View original content to download multimedia:https://www.prnewswire.com/news-releases/orien-member-presentations-at-2023-asco-demonstrate-unique-value-of-aster-insights-data-301836730.html SOURCE Aster Insights |
||
|
||
Copyright 2023 PR Newswire Association LLC. | Back to overview list |